{"hands_on_practices": [{"introduction": "The cornerstone of effective paronychia management is accurately distinguishing between its acute and chronic forms, as their pathophysiologies and treatment strategies diverge significantly. This first practice presents a classic clinical scenario to challenge your diagnostic acumen. By analyzing the patient's history, occupational exposures, and physical findings, you will apply the modern understanding of chronic paronychia as a primary inflammatory dermatitis, not a simple infection, to select the correct, mechanism-based management plan [@problem_id:4406153].", "problem": "A food-preparation worker presents with persistent swelling and erythema of the proximal and lateral nail folds of a single finger after repeated exposure to soaps and occlusive gloves at work. The symptoms have been present for $10$ weeks, with intermittent mild tenderness but no frank abscess. On examination, the cuticle is absent, the proximal nail fold appears boggy and shiny, and the nail plate shows mild ridging. There are no grouped vesicles. A potassium hydroxide (KOH) mount demonstrates budding yeasts consistent with Candida, and aerobic bacterial culture is negative. The patient is otherwise healthy and afebrile. Using only foundational definitions of inflammatory nail-fold disease by duration and pathophysiology, select the option that best classifies this case and defends the management strategy based on mechanism rather than organism alone.\n\nA. Acute bacterial paronychia; perform incision and drainage and prescribe a short course of an oral anti-staphylococcal antibiotic; addressing wet work or barrier repair is unnecessary once the abscess is treated.\n\nB. Chronic paronychia construed as a primary Candida infection; treat with prolonged systemic fluconazole monotherapy and avoid topical corticosteroids to prevent fungal proliferation.\n\nC. Chronic paronychia as an inflammatory dermatitis of the nail folds due to chronic irritant or allergen exposure with secondary Candida colonization; institute exposure reduction (minimize wet work, use cotton-lined gloves), barrier repair with emollients, and a mid- to high-potency topical corticosteroid to the proximal nail fold, with an adjunct topical imidazole if needed; cuticle re-formation is expected as inflammation resolves.\n\nD. Herpetic whitlow; initiate oral acyclovir and perform incision and drainage if tense vesicles appear to decompress the lesion.\n\nE. Ingrown nail-related paronychia; perform partial lateral nail avulsion with phenolization of the matrix to correct the driving anatomic cause.", "solution": "The problem statement is first subjected to validation.\n\n**Step 1: Extract Givens**\n- **Patient Profile**: Food-preparation worker.\n- **Clinical Presentation**: Persistent swelling and erythema of the proximal and lateral nail folds of a single finger.\n- **Duration**: Symptoms have been present for 10 weeks.\n- **Associated Symptoms**: Intermittent mild tenderness, no frank abscess.\n- **Occupational History**: Repeated exposure to soaps and occlusive gloves at work.\n- **Physical Examination Findings**:\n    - Absent cuticle.\n    - Boggy and shiny proximal nail fold.\n    - Mild ridging of the nail plate.\n    - Absence of grouped vesicles.\n- **Laboratory Findings**:\n    - Potassium hydroxide (KOH) mount: Positive for budding yeasts consistent with *Candida*.\n    - Aerobic bacterial culture: Negative.\n- **General Health**: Patient is otherwise healthy and afebrile.\n- **Task Constraint**: Classification and management must be based on foundational definitions by duration and pathophysiology, focusing on the mechanism rather than the organism alone.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem statement is scientifically grounded, well-posed, and objective.\n- **Scientific Grounding**: The clinical vignette is a classic and medically accurate representation of chronic paronychia. The described signs, symptoms, duration, risk factors (wet work), and microbiological findings are entirely consistent with established dermatologic principles and literature.\n- **Well-Posedness**: The provided data is complete and internally consistent, allowing for a clear diagnostic conclusion based on the specified constraints (duration and pathophysiology). It is structured to test the understanding of the distinction between acute and chronic paronychia and the modern pathophysiological model of the latter.\n- **Objectivity**: The description uses precise, objective clinical terminology.\n\n**Step 3: Verdict and Action**\nThe problem is valid. The solution process will now proceed.\n\n**Principle-Based Derivation**\nThe diagnosis and management strategy can be derived from foundational principles of inflammatory nail-fold disease.\n\n1.  **Classification by Duration**: Paronychia, the inflammation of the periungual tissues, is fundamentally classified by its duration.\n    - **Acute paronychia** is defined as lasting less than 6 weeks. It is typically infectious, most commonly caused by bacteria like *Staphylococcus aureus*, and often presents with a frank abscess.\n    - **Chronic paronychia** is defined as lasting 6 weeks or longer. The patient's symptoms have persisted for 10 weeks, which unequivocally places the condition in the chronic category.\n\n2.  **Pathophysiology of Chronic Paronychia**: The core mechanism is distinct from acute paronychia.\n    - It is primarily considered an **inflammatory process**, an eczematous or contact dermatitis of the nail folds, rather than a primary infection.\n    - The initiating event is the disruption of the physical barrier of the cuticle. In this case, repeated exposure to irritants (soaps) and maceration from moisture trapped by occlusive gloves (wet work) are the clear inciting factors.\n    - The loss of the cuticle's seal allows irritants, allergens, and moisture to penetrate the potential space between the proximal nail fold and the nail plate. This initiates and perpetuates a cycle of inflammation.\n    - The resulting chronically inflamed, boggy, and moist environment becomes secondarily colonized by microorganisms. *Candida* species are the most common colonizers, as confirmed by the KOH mount. The negative bacterial culture further supports a non-bacterial primary process.\n    - Therefore, the *Candida* is a consequence, not the primary cause, of the disease. Management must target the underlying dermatitis and barrier breakdown.\n\n**Derivation of Correct Management**\nBased on this pathophysiological model, a logical, mechanism-based management plan must include:\n1.  **Cessation of Insult**: Reducing exposure to the primary irritants and moisture. This involves behavioral changes and protective measures.\n2.  **Suppression of Inflammation**: Directly treating the underlying dermatitis with anti-inflammatory agents.\n3.  **Barrier Restoration**: Promoting the regrowth of the cuticle.\n4.  **Control of Secondary Colonization**: Reducing the microbial load, which is best achieved by altering the inflammatory environment and, if necessary, using adjunct topical antimicrobial agents.\n\n**Option-by-Option Analysis**\n\n**A. Acute bacterial paronychia; perform incision and drainage and prescribe a short course of an oral anti-staphylococcal antibiotic; addressing wet work or barrier repair is unnecessary once the abscess is treated.**\n- **Analysis**: This option is incorrect on multiple grounds. The diagnosis of acute paronychia is wrong based on the 10-week duration. The proposed management targets a bacterial abscess, but the patient has no abscess and a negative bacterial culture. The assertion that barrier repair is unnecessary is a critical error, as it ignores the fundamental cause of the chronic condition.\n- **Verdict**: **Incorrect**.\n\n**B. Chronic paronychia construed as a primary Candida infection; treat with prolonged systemic fluconazole monotherapy and avoid topical corticosteroids to prevent fungal proliferation.**\n- **Analysis**: This option correctly identifies the condition as chronic but misattributes the primary cause to *Candida* infection. This reflects an outdated pathophysiological model. The cornerstone of modern treatment is controlling inflammation; thus, avoiding topical corticosteroids is contraindicated as it fails to address the primary problem (dermatitis). Systemic antifungal monotherapy is not first-line and does not correct the underlying barrier defect and inflammation that allows the yeast to thrive.\n- **Verdict**: **Incorrect**.\n\n**C. Chronic paronychia as an inflammatory dermatitis of the nail folds due to chronic irritant or allergen exposure with secondary Candida colonization; institute exposure reduction (minimize wet work, use cotton-lined gloves), barrier repair with emollients, and a mid- to high-potency topical corticosteroid to the proximal nail fold, with an adjunct topical imidazole if needed; cuticle re-formation is expected as inflammation resolves.**\n- **Analysis**: This option provides a perfectly accurate description of the diagnosis, pathophysiology, and management. It correctly identifies the condition as chronic paronychia secondary to irritant dermatitis, with *Candida* as a secondary colonizer. The management plan is comprehensive and mechanistically sound: it addresses the cause (exposure reduction), the primary inflammation (topical corticosteroid), secondary colonization (adjunct topical imidazole), and barrier repair. This aligns exactly with the derived principles.\n- **Verdict**: **Correct**.\n\n**D. Herpetic whitlow; initiate oral acyclovir and perform incision and drainage if tense vesicles appear to decompress the lesion.**\n- **Analysis**: This diagnosis is inconsistent with the clinical findings. The problem explicitly states there are \"no grouped vesicles,\" which are the hallmark of herpetic whitlow. The chronic 10-week course is also atypical for herpes simplex virus infection in an immunocompetent host. Additionally, incising herpetic vesicles is generally contraindicated.\n- **Verdict**: **Incorrect**.\n\n**E. Ingrown nail-related paronychia; perform partial lateral nail avulsion with phenolization of the matrix to correct the driving anatomic cause.**\n- **Analysis**: This option proposes a cause (ingrown nail) and a treatment that do not match the presentation. Chronic paronychia from irritant exposure characteristically affects the proximal nail fold, causing it to become boggy with loss of the cuticle, as described. While an ingrown nail causes paronychia, it typically affects the lateral folds due to nail plate pressure and lacks the specific occupational history and proximal fold findings seen here. The proposed surgical intervention is inappropriate.\n- **Verdict**: **Incorrect**.", "answer": "$$\\boxed{C}$$", "id": "4406153"}, {"introduction": "When acute paronychia progresses to a fluctuant abscess, prompt surgical drainage is the definitive treatment. The choice of procedure, however, is not one-size-fits-all; it demands a precise application of anatomical knowledge to be both effective and safe. This exercise requires you to decide between two common drainage techniques based on the abscess's location, with the critical goal of evacuating purulence while preserving the underlying germinal matrix to prevent permanent nail damage [@problem_id:4406168].", "problem": "A patient presents with acute hand pain and swelling localized to the nail unit after repeated wet work and minor trauma. Examination reveals two distinct patterns depending on the affected digit. On one digit, there is a tense, fluctuant, erythematous swelling limited to the lateral nail fold without visible separation of the proximal nail fold. On another digit, there is marked tenderness under the proximal nail fold, loss of the onychocuticle seal, and transillumination demonstrates a well-circumscribed fluid collection extending beneath the eponychial fold overlying the proximal nail plate. There is no systemic toxicity, and capillary refill is intact. The clinical goal is complete evacuation of purulence with preservation of the germinal matrix and minimization of scarring.\n\nUse the foundational definitions and principles below to construct the correct procedural decision rule distinguishing when to perform a simple puncture incision versus partial elevation of the proximal nail plate:\n\n- Nail unit anatomy: the eponychial (proximal) nail fold overlies the proximal nail plate and germinal matrix; the lateral nail folds flank the nail plate; the onychocuticle forms a seal between the eponychium and the nail plate; the germinal matrix lies beneath the proximal nail fold and is responsible for nail production; the sterile matrix lies distal to the lunula beneath the nail plate.\n- Surgical principles: incision and drainage should access the abscess cavity via the shortest, dependent path while avoiding injury to structures that, if scarred, cause permanent dysfunction; pus follows a pressure gradient and accumulates in potential spaces; incisions through the proximal nail fold risk germinal matrix injury; lifting the proximal edge of the nail plate provides access to subeponychial collections without cutting the proximal nail fold; wick placement can maintain drainage after decompression.\n- Clinical triage: acute paronychia with fluctuance is managed by drainage; chronic paronychia without fluctuance is managed non-surgically with avoidance of irritants, topical anti-inflammatory therapy, and antifungal coverage if Candida species are suspected.\n\nWhich option best specifies an evidence-based plan that correctly chooses between puncture incision and partial proximal nail plate elevation based on whether the abscess is confined to the lateral nail fold versus extending beneath the eponychial fold, and that adheres to the above principles, including protection of the germinal matrix?\n\nA. If fluctuance is confined to the lateral nail fold and does not extend beneath the eponychial fold, perform a single puncture incision at the most dependent point of the lateral fold using an $18$-gauge needle or a small stab incision, gently milk out purulence, and place a small wick for 24 to 48 hours; avoid manipulating the nail plate. If the collection extends subeponychially under the proximal nail fold, avoid incising the proximal fold; instead, partially elevate approximately $2$ to $3$ $\\mathrm{mm}$ of the proximal nail plate with a spatula or elevator to access and decompress the cavity, then place a wick. Use a Digital Nerve Block (DNB) with 1 to 2 mL of local anesthetic per side as needed, and institute warm soaks afterwards. Reserve oral antibiotics for surrounding cellulitis or systemic risk factors.\n\nB. For any abscess adjacent to the eponychial fold, perform a transverse incision across the proximal nail fold to maximize exposure and drainage, avoid nail plate manipulation to minimize pain, and suture the proximal fold after evacuation; antibiotics are mandatory for all cases.\n\nC. For lateral abscesses that appear to extend beneath the eponychial fold, create a longitudinal incision through both the lateral and proximal nail folds to fully open the cavity; avoid nail plate elevation because it risks onycholysis; do not use a wick as it delays healing.\n\nD. Delay any invasive intervention and treat both presentations with oral antibiotics for $72$ $\\mathrm{hours}$ and warm soaks; perform drainage only if fever or lymphangitis develops, as incisions near the nail unit commonly cause scarring.\n\nE. In chronic paronychia with non-fluctuant swelling of the proximal nail fold, perform partial proximal nail avulsion and stab incision to break the onychocuticle seal and drain occult fluid; wick placement is recommended for 48 hours to prevent resealing.\n\nChoose the single best option.", "solution": "### Problem Validation\n\n**Step 1: Extract Givens**\n\nThe problem statement provides the following information:\n\n*   **Clinical Presentation**: A patient with acute hand pain and swelling of the nail unit after wet work and trauma.\n    *   **Presentation 1**: \"tense, fluctuant, erythematous swelling limited to the lateral nail fold without visible separation of the proximal nail fold.\"\n    *   **Presentation 2**: \"marked tenderness under the proximal nail fold, loss of the onychocuticle seal, and transillumination demonstrates a well-circumscribed fluid collection extending beneath the eponychial fold overlying the proximal nail plate.\"\n*   **Patient Status**: No systemic toxicity, intact capillary refill.\n*   **Clinical Goal**: \"complete evacuation of purulence with preservation of the germinal matrix and minimization of scarring.\"\n*   **Foundational Principles**:\n    *   **Nail unit anatomy**: The eponychial (proximal) nail fold overlies the proximal nail plate and germinal matrix; the lateral nail folds flank the nail plate; the onychocuticle forms a seal between the eponychium and the nail plate; the germinal matrix lies beneath the proximal nail fold and is responsible for nail production.\n    *   **Surgical principles**: Incision and drainage (I&D) should use the shortest, dependent path, avoid injury to structures causing permanent dysfunction (e.g., germinal matrix); pus follows a pressure gradient; incisions through the proximal nail fold risk germinal matrix injury; lifting the proximal edge of the nail plate accesses subeponychial collections without cutting the proximal nail fold; a wick can maintain drainage.\n    *   **Clinical triage**: Acute paronychia with fluctuance requires drainage. Chronic paronychia without fluctuance is managed non-surgically.\n\n**Step 2: Validate Using Extracted Givens**\n\nThe problem statement is evaluated against the validation criteria:\n\n1.  **Scientifically Grounded**: The problem is grounded in established medical science, specifically dermatology and minor surgery. The description of acute paronychia, its clinical variations (simple lateral vs. subeponychial), the relevant anatomy, and the principles of surgical management are all factually correct and consistent with standard medical practice.\n2.  **Well-Posed**: The problem is well-posed. It presents a clear clinical scenario with two distinct, well-described presentations. It provides a set of guiding principles and asks the solver to choose the management plan that best aligns with these principles. The goal is explicit and a unique, best-fit solution among the options is expected.\n3.  **Objective**: The language is objective, precise, and clinical. Terms like \"fluctuant,\" \"erythematous,\" \"onychocuticle,\" and \"germinal matrix\" are standard and unambiguous in this context.\n4.  **Completeness**: The problem is self-contained. It provides all necessary information—the clinical findings, the underlying principles, and the goal—to arrive at a logical conclusion.\n\n**Step 3: Verdict and Action**\n\nThe problem is **valid**. It is a well-formulated clinical reasoning question based on sound anatomical and surgical principles. The solution process can proceed.\n\n### Solution Derivation\n\nThe core of the problem is to apply the given principles to select the appropriate drainage procedure for two different localizations of an acute paronychia abscess.\n\n1.  **Analyze Presentation 1 (Lateral Fold Abscess)**: The abscess is described as \"limited to the lateral nail fold.\" The guiding surgical principle is to access the abscess \"via the shortest, dependent path while avoiding injury to structures that, if scarred, cause permanent dysfunction.\" The germinal matrix lies under the proximal nail fold, not the lateral fold. Therefore, a direct incision into the fluctuant lateral fold is the most direct drainage route and poses minimal risk to the germinal matrix.\n\n2.  **Analyze Presentation 2 (Subeponychial Abscess)**: The abscess is described as extending \"beneath the eponychial fold overlying the proximal nail plate.\" The principles explicitly state that \"incisions through the proximal nail fold risk germinal matrix injury\" and \"[one should] avoid injury to structures that, if scarred, cause permanent dysfunction.\" This directly contraindicates any procedure that cuts the skin of the proximal nail fold. The principles provide an alternative: \"lifting the proximal edge of the nail plate provides access to subeponychial collections without cutting the proximal nail fold.\" This is the key maneuver for this presentation, as it allows drainage while preserving the overlying eponychium and the underlying germinal matrix.\n\n3.  **Synthesize the Decision Rule**:\n    *   For a simple, fluctuant abscess confined to the lateral fold, a simple puncture or small stab incision into the lateral fold is appropriate.\n    *   For an abscess that has extended under the eponychium (proximal fold), the proximal nail plate should be gently elevated to allow drainage, thereby avoiding an incision through the eponychium and protecting the germinal matrix.\n\n### Option-by-Option Analysis\n\n**A. If fluctuance is confined to the lateral nail fold and does not extend beneath the eponychial fold, perform a single puncture incision at the most dependent point of the lateral fold using an $18$-gauge needle or a small stab incision, gently milk out purulence, and place a small wick for 24 to 48 hours; avoid manipulating the nail plate. If the collection extends subeponychially under the proximal nail fold, avoid incising the proximal fold; instead, partially elevate approximately $2$ to $3$ $\\mathrm{mm}$ of the proximal nail plate with a spatula or elevator to access and decompress the cavity, then place a wick. Use a Digital Nerve Block (DNB) with 1 to 2 mL of local anesthetic per side as needed, and institute warm soaks afterwards. Reserve oral antibiotics for surrounding cellulitis or systemic risk factors.**\n\n*   **Analysis**: This option perfectly matches the derived decision rule. It correctly differentiates the management based on the abscess location. For the lateral fold abscess, it recommends a direct, minimally invasive puncture/incision, consistent with the \"shortest path\" principle. For the subeponychial abscess, it explicitly follows the guiding principle to \"avoid incising the proximal fold\" and instead \"partially elevate... the proximal nail plate.\" The ancillary recommendations (wick, DNB, warm soaks, selective antibiotics) are all standard and appropriate.\n*   **Verdict**: **Correct**.\n\n**B. For any abscess adjacent to the eponychial fold, perform a transverse incision across the proximal nail fold to maximize exposure and drainage, avoid nail plate manipulation to minimize pain, and suture the proximal fold after evacuation; antibiotics are mandatory for all cases.**\n\n*   **Analysis**: This option directly violates a critical principle: \"incisions through the proximal nail fold risk germinal matrix injury.\" Performing a transverse incision across the proximal nail fold is an unnecessarily aggressive and risky procedure for acute paronychia, with a high likelihood of causing a permanent nail deformity. It also incorrectly recommends mandatory antibiotics, contradicting the triage guidelines.\n*   **Verdict**: **Incorrect**.\n\n**C. For lateral abscesses that appear to extend beneath the eponychial fold, create a longitudinal incision through both the lateral and proximal nail folds to fully open the cavity; avoid nail plate elevation because it risks onycholysis; do not use a wick as it delays healing.**\n\n*   **Analysis**: This option recommends incising the proximal nail fold, which violates the principle of protecting the germinal matrix. While nail plate elevation carries a small risk of onycholysis (separation of the nail from the bed), this is a far lesser concern than the near-certainty of permanent scarring and potential nail dystrophy from incising the germinal matrix. The recommendation against using a wick also contradicts the stated surgical principle to maintain drainage.\n*   **Verdict**: **Incorrect**.\n\n**D. Delay any invasive intervention and treat both presentations with oral antibiotics for $72$ $\\mathrm{hours}$ and warm soaks; perform drainage only if fever or lymphangitis develops, as incisions near the nail unit commonly cause scarring.**\n\n*   **Analysis**: This option contradicts the primary clinical triage principle provided: \"acute paronychia with fluctuance is managed by drainage.\" The problem describes two presentations of fluctuant abscesses. Delaying drainage allows the infection to worsen and can lead to more extensive tissue damage. While incisions can cause scarring, a well-placed, minimally invasive drainage procedure is the standard of care and is necessary to resolve the infection.\n*   **Verdict**: **Incorrect**.\n\n**E. In chronic paronychia with non-fluctuant swelling of the proximal nail fold, perform partial proximal nail avulsion and stab incision to break the onychocuticle seal and drain occult fluid; wick placement is recommended for 48 hours to prevent resealing.**\n\n*   **Analysis**: This option addresses the wrong clinical condition. The problem statement explicitly describes *acute* paronychia with fluctuance. Option E discusses *chronic* paronychia. Furthermore, it recommends an invasive procedure for a condition that the provided principles state \"is managed non-surgically\" if non-fluctuant.\n*   **Verdict**: **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "4406168"}, {"introduction": "No procedural intervention should begin without first ensuring patient safety. For the incision and drainage of an acute paronychia, this starts with the safe administration of local anesthesia. This final practice focuses on a foundational skill: calculating the maximum safe volume of an anesthetic agent based on patient weight and drug concentration, a critical step to prevent the risk of Local Anesthetic Systemic Toxicity (LAST) [@problem_id:4406114].", "problem": "A patient with acute paronychia of the right index finger requires incision and drainage under a digital nerve block. You intend to use lidocaine without epinephrine to avoid confounding vasoconstriction in an inflamed digit. For safety, you will not exceed a maximum dose to avoid Local Anesthetic Systemic Toxicity (LAST). Assume the following foundational facts:\n\n1. Maximum dose limits for local anesthetics are weight-based, so the maximum allowable mass of drug is obtained by multiplying the maximum dose per unit mass by the patient’s body mass.\n2. The definition of a percent solution by mass per volume is that a $1\\%$ solution contains $1\\,\\text{g}$ of solute per $100\\,\\text{mL}$ of solution, which implies a concentration in $\\text{mg/mL}$ by unit conversion.\n3. Dose-volume conversion follows from concentration, since volume equals drug mass divided by concentration.\n\nGiven a $70\\,\\text{kg}$ adult, a maximum lidocaine without epinephrine dose of $3\\,\\text{mg/kg}$, and a $1\\%$ lidocaine solution, derive from these principles the maximum safe injectable volume in milliliters for this patient. Round your final result to two significant figures and express the answer in mL.", "solution": "The problem will be validated by first extracting the given information and then assessing its scientific integrity and self-consistency.\n\n### Step 1: Extract Givens\n- Patient's body mass, $m_{\\text{patient}} = 70\\,\\text{kg}$.\n- Maximum dose of lidocaine without epinephrine, $D_{\\text{max}} = 3\\,\\text{mg/kg}$.\n- Lidocaine solution concentration is a $1\\%$ solution.\n- Principle 1: Maximum allowable mass of drug ($M_{\\text{drug}}$) = (maximum dose per unit mass) $\\times$ (patient's body mass).\n- Principle 2: A $1\\%$ solution contains $1\\,\\text{g}$ of solute per $100\\,\\text{mL}$ of solution.\n- Principle 3: Volume = (drug mass) $\\div$ (concentration).\n- The final result must be rounded to two significant figures and expressed in milliliters ($\\text{mL}$).\n\n### Step 2: Validate Using Extracted Givens\nThe problem is evaluated against the required criteria.\n- **Scientifically Grounded**: The problem describes a standard medical dose calculation. The value for the maximum dose of lidocaine without epinephrine ($3\\,\\text{mg/kg}$) is a clinically accepted conservative value (standard range is often cited as $3-5\\,\\text{mg/kg}$). The patient's mass is realistic. The principles of calculating total mass dose from a weight-based dosage, determining concentration from a percent solution, and computing volume from mass and concentration are fundamental and correct in chemistry and pharmacology. The clinical context is medically sound.\n- **Well-Posed**: The problem is well-posed as it provides all necessary data and definitions to arrive at a single, unique numerical answer. The relationships between mass, volume, and concentration are explicitly defined.\n- **Objective**: The problem is stated using precise, objective language without subjective or ambiguous terms.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. It is scientifically sound, well-posed, and objective. It is based on fundamental principles of chemistry and medicine and contains no internal contradictions or missing information. The solution process may proceed.\n\n### Solution Derivation\nThe objective is to calculate the maximum safe injectable volume ($V_{\\text{max}}$) of the specified lidocaine solution for the given patient. The derivation will follow the three principles provided in the problem statement.\n\n**First, calculate the maximum allowable mass of lidocaine, $M_{\\text{drug}}$.**\nAccording to Principle 1, the maximum mass of the drug is the product of the maximum dose per unit mass and the patient's body mass.\nLet $D_{\\text{max}} = 3\\,\\text{mg/kg}$ and $m_{\\text{patient}} = 70\\,\\text{kg}$.\n\n$$M_{\\text{drug}} = D_{\\text{max}} \\times m_{\\text{patient}}$$\n$$M_{\\text{drug}} = \\left(3\\,\\frac{\\text{mg}}{\\text{kg}}\\right) \\times (70\\,\\text{kg})$$\n$$M_{\\text{drug}} = 210\\,\\text{mg}$$\n\n**Second, determine the concentration of the lidocaine solution, $C$, in units of $\\text{mg/mL}$.**\nAccording to Principle 2, a $1\\%$ solution contains $1\\,\\text{g}$ of solute per $100\\,\\text{mL}$ of solution. To be dimensionally consistent with the calculated drug mass, this concentration must be converted from $\\text{g/mL}$ to $\\text{mg/mL}$. The conversion factor is $1\\,\\text{g} = 1000\\,\\text{mg}$.\n\n$$C = \\frac{1\\,\\text{g}}{100\\,\\text{mL}}$$\n$$C = \\frac{1\\,\\text{g}}{100\\,\\text{mL}} \\times \\frac{1000\\,\\text{mg}}{1\\,\\text{g}}$$\nBy canceling the units of grams ($\\text{g}$), we obtain:\n$$C = \\frac{1000\\,\\text{mg}}{100\\,\\text{mL}} = 10\\,\\frac{\\text{mg}}{\\text{mL}}$$\n\n**Third, calculate the maximum safe injectable volume, $V_{\\text{max}}$.**\nAccording to Principle 3, the volume is the drug mass divided by the concentration. We use the maximum allowable mass ($M_{\\text{drug}}$) to find the maximum safe volume ($V_{\\text{max}}$).\n\n$$V_{\\text{max}} = \\frac{M_{\\text{drug}}}{C}$$\nSubstituting the previously calculated values:\n$$V_{\\text{max}} = \\frac{210\\,\\text{mg}}{10\\,\\frac{\\text{mg}}{\\text{mL}}}$$\n$$V_{\\text{max}} = 21\\,\\text{mL}$$\n\n**Finally, apply the rounding requirement.**\nThe problem requires the final answer to be rounded to two significant figures. The calculated result, $21\\,\\text{mL}$, already has exactly two significant figures (the digits $2$ and $1$). Therefore, no further rounding is needed. The maximum safe injectable volume is $21\\,\\text{mL}$.", "answer": "$$\\boxed{21}$$", "id": "4406114"}]}